Regeneron Pharmaceuticals (REGN) shares outstanding

Shares outstanding · fiscal 2025
108.60M

Regeneron Pharmaceuticals (REGN) had 108.60M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 5.6% lower than the 115.10M of fiscal 2024. Figures as of 18 Nov 2026, 12:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
108.60M
Change on fiscal 2024
−5.6%
Growth, 5 years
−1.2% a year
Growth, 10 years
−0.6% a year
Highest on record
116.30Mfiscal 2016
Lowest on record
82.93Mfiscal 2010
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Regeneron Pharmaceuticals shares outstanding, in more detail

The market data feed counts 101.63M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count shrank at a compound 1.2% a year; over ten years the rate was −0.6% a year. Across the 16 fiscal years on record (2010–2025), the highest was 116.30M in fiscal 2016 and the lowest 82.93M in fiscal 2010.

History · 16 fiscal years

Shares outstanding by fiscal year

Regeneron Pharmaceuticals shares outstanding, year by year

Regeneron Pharmaceuticals (REGN) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025108.60M 5.6% down
2024115.10M 1.2% up
2023113.70M 0.2% up
2022113.50M 1.2% up
2021112.20M 2.5% down
2020115.10M 0.4% up
2019114.60M 0.2% down
2018114.80M 0.9% down
2017115.90M 0.3% down
2016116.30M 0.9% up
2015115.23M 1.6% up
2014113.41M 1.9% up
2013111.29M 3.5% down
2012115.38M 27.3% up
201190.61M 9.3% up
201082.93M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Regeneron Pharmaceuticals and comparable companies
CompanyShares outstandingFiscal year
Moderna MRNA389.00M2025
CVS Health CVS1.27B2025
HCA Healthcare HCA239.50M2025
GSK GSK2.06B2025
Regeneron Pharmaceuticals REGN108.60M2025
Elevance Health ELV224.60M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on REGN

Regeneron Pharmaceuticals, figure by figure

Regeneron Pharmaceuticals (REGN) overview: price, valuation and scorecardAll health care companies by market value

Regeneron Pharmaceuticals shares outstanding: questions and answers

How many shares does Regeneron Pharmaceuticals have?

Regeneron Pharmaceuticals (REGN) had 108.60M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 5.6% lower than the 115.10M of fiscal 2024. The market data feed counts 101.63M shares outstanding today.

What is the growth rate of Regeneron Pharmaceuticals's diluted share count?

Over the five fiscal years to 2025 the diluted share count shrank at a compound 1.2% a year; over ten years the rate was −0.6% a year.

What are the highest and lowest diluted share count figures on record for Regeneron Pharmaceuticals?

Across the 16 fiscal years on record (2010–2025), the highest was 116.30M in fiscal 2016 and the lowest 82.93M in fiscal 2010.

How is Regeneron Pharmaceuticals's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Regeneron Pharmaceuticals it is on record here for 16 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Regeneron Pharmaceuticals (REGN) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/REGN/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.